ETF Managers Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $298K | Buy |
163,948
+64,147
| +64% | +$117K | 0.01% | 538 |
|
|
2022
Q4 | $506K | Sell |
99,801
-18,326
| -16% | -$92.9K | 0.02% | 364 |
|
|
2022
Q3 | $587K | Sell |
118,127
-7,601
| -6% | -$37.8K | 0.02% | 349 |
|
|
2022
Q2 | $474K | Buy |
125,728
+5,063
| +4% | +$19.1K | 0.01% | 511 |
|
|
2022
Q1 | $711K | Buy |
120,665
+492
| +0.4% | +$2.9K | 0.01% | 385 |
|
|
2021
Q4 | $767K | Sell |
120,173
-22,652
| -16% | -$145K | 0.02% | 387 |
|
|
2021
Q3 | $1.37M | Buy |
142,825
+24,670
| +21% | +$237K | 0.03% | 237 |
|
|
2021
Q2 | $1.72M | Buy |
118,155
+80,521
| +214% | +$1.17M | 0.03% | 237 |
|
|
2021
Q1 | $894K | Sell |
37,634
-15,185
| -29% | -$361K | 0.02% | 290 |
|
|
2020
Q4 | $758K | Sell |
52,819
-7,723
| -13% | -$111K | 0.02% | 269 |
|
|
2020
Q3 | $435K | Buy |
60,542
+32,807
| +118% | +$236K | 0.01% | 335 |
|
|
2020
Q2 | $300K | Buy |
+27,735
| New | +$300K | 0.01% | 413 |
|